Page last updated: 2024-09-03

imatinib mesylate and Neoplasms, Vascular

imatinib mesylate has been researched along with Neoplasms, Vascular in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Coindre, JM; Debiec-Rychter, M; Dewaele, B; Finalet-Ferreiro, J; Fletcher, CD; Floris, G; Guillou, L; Hogendoorn, PC; Marynen, P; Schöffski, P; Sciot, R; Vandenberghe, P; Vanspauwen, V; Wozniak, A	1

Other Studies

1 other study(ies) available for imatinib mesylate and Neoplasms, Vascular

Article	Year
Coactivated platelet-derived growth factor receptor {alpha} and epidermal growth factor receptor are potential therapeutic targets in intimal sarcoma. Cancer research, 2010, Sep-15, Volume: 70, Issue:18 Topics: Adult; Aged; Benzamides; Comparative Genomic Hybridization; Dasatinib; ErbB Receptors; Female; Humans; Imatinib Mesylate; In Situ Hybridization, Fluorescence; Karyotyping; Male; Middle Aged; Phosphorylation; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Sarcoma; Thiazoles; Tunica Intima; Vascular Neoplasms	2010

Article

Year

Coactivated platelet-derived growth factor receptor {alpha} and epidermal growth factor receptor are potential therapeutic targets in intimal sarcoma.

Cancer research, 2010, Sep-15, Volume: 70, Issue:18

Topics: Adult; Aged; Benzamides; Comparative Genomic Hybridization; Dasatinib; ErbB Receptors; Female; Humans; Imatinib Mesylate; In Situ Hybridization, Fluorescence; Karyotyping; Male; Middle Aged; Phosphorylation; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Sarcoma; Thiazoles; Tunica Intima; Vascular Neoplasms

2010